key: cord-0844163-ns2pfiua authors: Stanczak, M. A.; Sanin, D. E.; Apostolova, P.; Nerz, G.; Lampaki, D.; Hofmann, M.; Steinmann, D.; Thimme, R.; Mittler, G.; Waller, C. F.; Pearce, E. J.; Pearce, E. L. title: IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals date: 2020-07-10 journal: nan DOI: 10.1101/2020.07.09.20148056 sha: a2b8fe3d34cea3fd5ebc052d4d19e99b79b22125 doc_id: 844163 cord_uid: ns2pfiua Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We investigated seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5-79 years). Seropositivity for SARS-CoV-2 spike glycoprotein aligned with PCR results that confirmed previous infection. Anti-spike IgG titers remained high 60 days post-infection and did not associate with symptoms, but spike-specific IgM did associate with malaise and fever. We found limited household transmission, with children of infected individuals seldomly seropositive, highlighting professional exposure as the dominant route of infection in our cohort. We analyzed PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist- activation revealed an increased population of IL-6+TNF-IL-1{beta}+ monocytes, while SARS-CoV-2 peptide stimulation elicited IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlated with CD4+ T cell activation in PBMCs from convalescent subjects, and was likely due to T cell-mediated effects on IL-33- producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 revealed a population of IL-33-producing cells that increases with disease. Together these findings show that IL-33 production is linked to SARS-CoV- 2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity. We took the opportunity to study a cohort of individuals with a known professional exposure, within a relatively small timeframe (~2-3 months), as the pandemic was developing. We assessed viral transmission among these individuals and their family members. Specifically, we used an ELISA to measure IgG and IgM titers against the SARS-CoV-2 spike glycoprotein 1 . Our study population included 155 subjects who either tested positive for SARS-CoV-2 via PCR or were in contact with SARS-CoV-2-infected individuals. Demographic and disease characteristics of the study population are indicated in Supplementary (28.4%) were exposed within their household and 12 subjects had either multiple or different/unknown exposure sources. Symptoms of upper respiratory tract infection within the last 16 weeks prior to blood collection were reported by 97 (62.6%) individuals. SARS-CoV-2 PCR testing was performed in 87 individuals, with 47 (30.3%) having a positive PCR result. We evaluated the presence and abundance of antibodies against the spike protein of SARS-CoV-2 in the serum of the study population, as well as in 16 historical sera collected prior to the onset of the COVID-19 pandemic. We found highest antibody titers among individuals with a positive SARS-CoV-2 PCR ( Fig. 1a ) , as well as a few cases where subjects with a negative PCR result possessed antibodies against the viral protein (9/40). As the date of the PCR and the collection of serum samples were separated by a median time of 49 days, it is possible that these individuals became infected after a PCR was carried out. Likewise, we discovered few cases (3/47) where a positive PCR result did not associate with elevated anti-spike IgG titers. We used the signal measured in pre-exposure sera to set a threshold to define seropositive and borderline cases ( Fig. 1a -black and red dashed lines respectively). This resulted in 5 borderline cases and 65 seropositive individuals. We then probed collected sera for IgG and IgM antibodies against the spike protein and its receptor binding domain (RBD) finding a robust correlation between these measurements ( Fig. 1b-c, i and Extended Data Fig. 1a-e ) . Most seropositive subjects reported experiencing symptoms ( Fig. 1d ) . We discovered only 6 asymptomatic individuals out of 65 seropositive subjects (2/8 borderline cases) who nonetheless had high anti-spike IgG titers ( Fig. 1d ) although anti-RBD IgG titers were appreciatively lower ( Fig. 1e ). We found no association between sex and antibody titers ( Fig. 1f-g ) . To explore possible links between clinical features and antibody titers, we probed our data with two complementary strategies. First, we fitted logistic regression models to reported symptoms among seropositive subjects ( Fig. 1h and Extended Data Fig. 1f-h ) , setting the symptom report (yes = 1, no = 0) as the outcome predicted by the antibody titer and calculating the deviance of the model as a measure of accuracy. Within our cohort, elevated IgM levels against spike and RBD were reasonable predictors of experiencing malaise and fever ( Fig. 1h and Extended Data Fig. 1f-g ) , but not for other symptoms ( Extended Data Fig. 1h ). These results might suggest that people with strong immune responses against the virus feel sicker during acute infection, but also have persistent IgM antibodies as a result of this stronger antiviral response. Next, we calculated the Kendall's rank correlation coefficient ( ) between symptom duration, subject age, and antibody titers in pairs ( Fig. 1i ). Beyond the strong correlation between IgG and IgM titers for both 4 protective immunity 2 , it is probable that the pathologic effects of SARS-CoV-2 infection are cell-mediated. The development of IgG antibodies during infection is indication that a CD4 + T follicular helper cell response is mounted against this virus 3, 4 , and recent work has indicated that both CD4 + and CD8 + T cells capable of making IFN-γ and TNF are present within the blood of convalescent patients [4] [5] [6] . We therefore decided to look broadly at cellular immune responses in convalescent patients. We focused on both SARS-CoV-2 spike protein-specific T cell responses and innate monocyte responses, and measured cytokines known to be produced by both adaptive and innate immune cells. We did this for a subset of 20 convalescent individuals in our cohort, comparing them to 20 seronegative subjects in our study (Supp. Table 2 ). We purified PBMCs from these individuals and examined their composition ( Fig. 3a -d ) and activation following stimulation ( Fig. 3a , e-h ), correlating these results to antibody titers ( Fig. 3 in bold) using conventional markers ( Extended Data Fig. 2 ) and 2 different stimuli ( Fig. 3a ) . Overall, we did not detect a strong association between the cellular composition, immune cell activation, time from active infection, and antibody titers, ( Fig. 3 and Extended Data Fig. 3 ) with the latter more closely associated with subject age than any other measured parameter ( Fig. 3b-f ). We also observed a bimodal distribution of seropositive subjects, with the studied population clustering in 2 separate groups ( Fig. 3 ) indicating an underlying complexity in our cohort. However, upon examination of TLR7-driven classical monocyte activation ( Fig. 3g ), we discovered that the percentage of IL-6 + TNF -IL-1β + monocytes clustered closely with IgG titers. Moreover, SARS-CoV-2 peptide-induced production of IL-33, IL-6, IFN-ɑ2 and IL-23 in these cultures ( Fig. 3h ) also clustered together with IgG titers. Critically, IL-33 production was more 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 10, 2020. . https: //doi.org/10.1101 //doi.org/10. /2020 closely related to IgG titers than any other measured parameter ( Extended Data Fig. 3 ), including subject age. While resistance to infection is likely to involve cytokines such as IFN-γ produced by T cells, many of the symptoms associated with severe COVID-19 appear to be linked to excessive production of innate cytokines such as IL-6 and IL-1β 7 . Consequently, we felt that the results highlighting IL-33, IL-6, IFN-ɑ2, IL-23 and IL-1β production ( Fig. 3 ) could be important. In line with our clustering analysis, we found that all highlighted features were in fact significantly increased in seropositive subjects ( Fig. 4a-e ). We reasoned that the observed cytokine production ( Fig. 4a-d ) should be a result of T cell activation, as our experimental strategy favours this mechanism. We found that this could be the case for IL-33, which had a strong positive correlation with CD69 expression in CD4 + T cells ( Fig. 4f ). However, this was not the case for other parameters ( Fig. 4g -i ) and not unexpectedly for the percentage of IL-6 + TNF -IL-1β + monocytes ( Fig. 4j ). To our knowledge, there are no reports associating IL-33 with COVID-19 and given the strong correlation we observed in our data we decided to explore this result in more detail. To accomplish this, we retrieved single cell RNA sequencing data from a recent publication 8 and processed it to interrogate IL33 expression in the setting of SARS-CoV-2 pulmonary disease ( Fig. 4k-q and Extended Data Fig. 4 ). These data were generated from cells in BALF of 3 healthy donors and 9 acutely SARS-CoV-2 infected patients, 3 of whom displayed mild symptoms, while the remaining 6 were classed as severely ill ( Extended Data Fig. 4 ). In these data, we identified 2 7 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . potential sources of IL-33 production coming from 3 distinct cell clusters ( Fig. 4k-l ) . Strikingly, IL33 expression was confined to SARS-CoV-2 infected patients ( Fig. 4m ), concomitant with the increased appearance of the IL33 + cell clusters as a result of disease ( Extended Data Fig. 4 ). IL33 + cell clusters were most likely stromal cells ( Fig. 4n-q ) and are unlikely to be responsible for the IL-33 production we observed in PBMC cultures. However, these clinical data further implicate IL-33 in COVID-19 immunobiology. Here we show that after the resolution of infection, an innate immune cytokine signature persists in PBMCs of convalescent subjects, characterized by induction of IL-33 in response to T cell activation with 14-mer peptides, a peptide length suggestive of CD4 + T cell activation 9 . However, the identity and mechanism of activation of the IL-33-producing cells in the PBMCs from convalescent individuals remain unclear at this time. IL-33 was initially described as a cytokine produced as an alarmin by epithelial cells to induce type 2 immune responses 10 , and of interest in this regard, there are reports of eosinophilia, a mark of type 2 immunity, in COVID-19 patients 11 . IL-33 is also linked to lung injury, pulmonary viral infections, and chronic lung diseases 12 . COVID-19 can cause complications such as pneumonia and acute respiratory distress syndrome, as well as invoke lasting damage to lungs, including lung remodeling and fibrosis, which are consistent with known roles of IL-33 13 . These observations suggest that IL-33 could participate in the pathogenesis of COVID-19. On the other hand, IL-33 has also been reported to promote antiviral cytotoxic T cell responses 14-16 and higher antibody production 17,18 . Thus the presence of a persistent population of cells capable of making IL-33 in response to T cell activation may 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint confer an advantage in the case of secondary exposure. Further work on IL-33 will be needed to elucidate the role of this cytokine in COVID-19. 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. 12 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . a , Anti-spike IgG titers shown as area under titration curve (AUC) in sera from investigated subjects grouped by SARS-CoV-2 PCR status (Negative, None, Positive) plus pre-pandemic historical sera (Preexp). Dotted lines illustrate estimated thresholds above which subjects were classified as "Borderline case" (mean + 2xSD 13 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint -red) or "Seropositive" (mean + 3xSD -black). Mean and SD were calculated for all IgG titers below maximum value measured from Preexp sera. b-g , Anti-spike (b, d, f) and anti-RBD (c, e, g) IgG titers shown as AUC for investigated subjects grouped by SARS-CoV-2 PCR status (b-c), reported symptoms (d-e) and sex (f-g). Subjects are colored by serology results. h , Detected antibody titers were used to fit logistic regression models to symptom reporting by seropositive subjects. Deviance from logistic model fitting is shown as a measure of model accuracy. i , Detected antibody titers from seropositive subjects were correlated to each other, symptom duration and subject age using a Kendall rank correlation. A heatmap of the Kendall rank correlation coefficient ( ) is shown for each pair of variables. j-k , Anti-spike (j) and anti-RBD (k) IgG titers shown as a function of time for seropositive subjects. Approximated time of infection was taken as day of positive SARS-CoV-2 PCR status. 14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint 15 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint c , Network assortativity, used as an indication of infection transmission rate, was calculated based on the indicated parameters for the network in b (red line) and also after parameter randomization over 10000 permutations of the network (shown as a distribution). 16 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint 17 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint a-h , PBMCs in blood collected from a subset of 20 seropositive and 20 seronegative subjects were isolated, analyzed via flow cytometry for cellular composition (b-d) and stimulated with a SARS-CoV-2 spike peptide mix or vehicle control (e-f, h), or with TLR7 agonist Resiquimod or vehicle control (g) for indicated times (a). Activation of CD3 + CD4 + (e), CD3 + CD8 + (f) and CD14 hi CD16cells (g) plus cytokine secretion into culture media (h) were measured via flow cytometry. Control corrected (treatment -control) scaled data ( ) was then visualized as heatmaps. Scaled 18 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint a-e , Cytokine production measured in the media of cultured PBMCs (a-d) or via intracellular staining of CD14 hi CD16monocytes from seropositive (purple) and 19 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint seronegative (green) subjects is shown as scaled values. Two tailed Mann-Whitney U tests were calculated and resulting p value is reported. f-j , Scaled cytokine production versus corresponding CD4 T cell activation (CD4 + CD69 + ) in PBMC cultures of seropositive individuals is shown. Linear regression curves fitted to these data (blue) alongside R 2 values are provided. 20 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint All procedures involving human subjects were approved by the Ethics Committee of the Medical Center -University of Freiburg (305/20). The study was registered at the German Clinical Trial Register ( DRKS00022292 ). Pre-exposure donor serum samples (n=16) had been collected, aliquoted and stored at the Medical Center -University of Freiburg prior to June 1st, 2019. These individuals were considered to be pre-exposure controls since their biological material had been stored prior to the emergence of SARS-CoV-2. This cohort included 50% males (n=8) and 50% females. Median age was 51 years with a range of 39-77 years. SARS-CoV-2-exposed subjects (n=155) were recruited with a standardized procedure based on assessment of inclusion and exclusion criteria. Inclusion criteria were contact to SARS-CoV-2-infected individuals, age of at least 5 years and the ability to provide a written informed consent. The exclusion criterium was the presence of symptoms of an acute SARS-CoV-2 infection (fever, cough, malaise) within the last 14 days prior to blood collection. Study participants gave their written informed consent prior to study enrollment. For subjects <18 years of age, written informed consent was provided by one parent. Collection of biological material was performed at the Medical Center -University of Freiburg. Serum and peripheral blood mononuclear cells (PBMCs) were collected at one or two time points. All samples were de-identified and analyzed in a pseudonymized manner. Information on demographic characteristics and disease course was provided by the subjects using a standardized questionnaire filled at the time point of enrollment. Information on age, sex, PCR testing for SARS-CoV-2, symptoms, symptom duration, treatment 21 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. Serum was collected in tubes containing clot activators (7.5 ml) and stored at room temperature prior to processing. Tubes were centrifuged at 2500 g for 10 min and serum was aliquoted and stored at -20 °C. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. Plates were washed four times with PBS/T and developed using a TMB substrate kit (Biolegend) for 5 min at room temperature. Colorimetric reaction was stopped by the addition of 2N H 2 SO 4 . Internal positive and negative standards were included on each plate to allow for data normalization between different plates. Absorbance at 450 nm was measured using a TriStar microplate reader (Berthold Technologies). Peripheral blood from 20 seronegative and 20 seropositive subjects (based on anti-spike IgG ELISA) was collected in EDTA-coated tubes and stored at 4 °C prior to processing. Blood was diluted 1:1 with PBS containing 2% FCS and 1 mM EDTA. Peripheral blood mononuclear cells (PBMCs) were isolated using a density gradient method. Lymphoprep solution (Stem Cell) was pipetted to the bottom of SepMate-50 tubes (Stem Cell), and diluted blood carefully layered on top. After 10 min centrifugation at 1200 x g, the upper phase containing mononuclear cells was transferred to a new tube. PBMCs were washed twice with PBS with 2% FCS and 1 mM EDTA. After counting, cells were aliquoted, frozen in FCS containing 10% DMSO and stored at -80 °C. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https: //doi.org/10.1101 //doi.org/10. /2020 Flow cytometry data were analyzed using FlowJo version 10.6. Clinical data, ELISA readings, flow cytometry results and single cell RNA sequencing data were processed and analyzed using R (Lucent Technologies), which was also employed to generate graphs. Background measurements were subtracted from absorbance readings, which were then batch corrected based on internal standards included on each plate. Batch and background corrected data were then used to calculate the area under the dilution curve (AUC) for each subject. To calculate a seropositivity threshold, a subset of AUC values was extracted, composed of all pre-pandemic sera as well as those subjects with an AUC lower than the maximum obtained from pre-exposure sera and with no SARS-CoV-2 PCR or with a negative PCR result. Borderline cases were defined as being 2 standard deviations away from the mean AUC from this sample subset, while AUC results at least 3 standard deviations away from the mean were taken as seropositive. All other values were defined as seronegative. The relationship between antibody titers, subject age and reported symptoms were explored in two parallel ways. First, antibody titers were used to fit a logistic regression model capable of predicting the presence of reported symptoms (yes = 1, no = 0). The deviance of each model was used to estimate the quality of the fit. Next, antibody titers, subject age, and symptom duration in days were correlated with one another using Kendall's rank correlation and reporting as the correlation coefficient. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10. 1101 Only complete pairs of observations were used in correlations and all data was scaled by subtracting the mean of each feature and dividing by the corresponding standard deviation. An adjacency matrix was generated for the network of subject interactions based on reported exposures. Subjects with suspected professional exposure to SARS-CoV-2, who shared a workplace, were connected to each other. Subjects belonging to the households of professionally exposed individuals were added to the network, with interactions within households included. Only subjects with known professional exposure and with at least one household connection were included in this analysis. To estimate viral transmission within households, a network was constructed exclusively with household interactions and later the assortativity of the network was estimated with regards to serological results and antibody titers. Observed assortativities were compared to those calculated based on 10000 permutations of used values over the same network architecture. Network visualization, analysis and construction was performed with igraph v.1.2.5. Flow cytometry results were collected and stimulation controls were subtracted from values obtained for treatments. Corrected values were subsequently scaled and clustered based on Euclidean distances to antibody titers and subject age, which were similarly scaled. Heatmaps and clustering were obtained by using pheatmap v.1.0.12. Selected features were correlated with one another using a linear 27 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint regression model (y ~ x) and reporting R squared as an indication of the quality of the fit. The transcriptional profiles of ~90000 single cells in bronchoalveolar lavage fluid from 3 healthy individuals and 9 SARS-CoV-2 infected patients (3 with mild and 6 with severe disease) were retrieved from a publicly available repository (GSE145926). Matrices with raw unfiltered read counts for detected features in barcoded cells were downloaded for each subject and subsequently processed, analyzed and visualized in R using Seurat v. 3 19 , removing cells with a high percentage of mitochondrial RNA over total RNA (> 25%) and with less than 200 detected features, normalizing gene expression data by applying regularized negative binomial regression 20 and using a Uniform Manifold Approximation and Projection (UMAP) 21 as a dimensionality reduction approach. Differentially expressed genes within each cluster and across conditions were determined with Seurat as those with a greater than 1.2 fold change and an adjusted p value of less than 0.05. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 10, 2020. 38 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 10, 2020. . 42 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 10, 2020. . https://doi.org/10.1101/2020.07.09.20148056 doi: medRxiv preprint A serological assay to detect SARS-CoV-2 seroconversion in humans. medRxiv (2020) A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Median age (range), years 36 (5-79) 34 (5-62) Sex female -no. (%) male -no SARS-CoV2 PCR Positive -no. (%) Negative -no. (%) Not performed -no. (%) Symptoms Cephalgia Prevalence -no. (%) Median duration -days (range) Malaise Prevalence -no. (%) Median duration -days (range) Cough Prevalence -no. (%) Median duration -days (range) Fever Prevalence -no. (%) Median duration -days (range) Musculoskeletal pain Prevalence -no. (%) Median duration -days (range) Anosmia Prevalence -no. (%) Median duration -days (range) Pharyngitis Prevalence -no. (%) Median duration -days (range) Dyspnea Prevalence -no. (%) Median duration -days (range) The authors would like to thank Yvonne Neumann, Johan Fridén, Florian Krammer, Mauro Corrado, Asifa Akhtar, Bertram Bengsch, Martin Schwemmle, Evelyn Pearce,